Keyphrases
Head-and-neck Cancer
100%
Overcoming Resistance
100%
Human Papillomavirus Negative
100%
EGFR Inhibition
100%
Cetuximab
75%
Chemotherapy
25%
Monoclonal Antibody
25%
Response Rate
25%
Head-and-neck
25%
High-risk Human Papillomavirus (HR-HPV)
25%
Resistance Mechanisms
25%
Improved Outcomes
25%
Histone Deacetylase 1 (HDAC1)
25%
Targeted Therapy
25%
Receptor Tyrosine Kinase
25%
Disease Survival
25%
Carcinogen
25%
Cure Rate
25%
Effects on Survival
25%
Human Epidermal Growth Factor Receptor 2 (HER2)
25%
Cytotoxic Chemotherapy
25%
Novel Therapies
25%
Nuclear Function
25%
Cell Trafficking
25%
Decoy
25%
Aurora Kinase Inhibitor
25%
Active Therapy
25%
EGFR Signaling
25%
Medicine and Dentistry
Epidermal Growth Factor Receptor
100%
Wart Virus
100%
Head and Neck Cancer
100%
Cetuximab
50%
Malignant Neoplasm
16%
Infection
16%
Disease
16%
Monoclonal Antibody
16%
Protein Tyrosine Kinase
16%
Neck
16%
Cell Migration
16%
Carcinogen
16%
Histone Deacetylase
16%
Cytotoxic Chemotherapy
16%
Targeted Therapy
16%
Aurora Kinase Inhibitor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Head and Neck Cancer
100%
Human Papillomavirus
100%
Cetuximab
50%
Malignant Neoplasm
16%
Monoclonal Antibody
16%
Disease
16%
Infection
16%
Chemotherapy
16%
Carcinogen
16%
Protein Tyrosine Kinase
16%
Cytotoxic Chemotherapy
16%
Histone Deacetylase
16%
Aurora Kinase Inhibitor
16%